NIRMIDAS BIOTECH, INC.
Medtech · Private
Automated multiplexed diagnostic assay for type 1 diabetes autoantibody detection using nanoscience-based pGOLD platform
- Grants
- $1.5M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 14
- 2 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a plasmonic-based multiplexed platform for Diagnosis and Screening of Type 1 Diabetes and related Auto-Immune Diseases | $206,973 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of multiplexed autoantibody test on pGOLD platform for Diagnosis and Screening of Type 1 Diabetes | $496,692 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of multiplexed autoantibody test on pGOLD platform for Diagnosis and Screening of Type 1 Diabetes | $804,811 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1587 | OMNECOIL INSTRUMENTS, INC. | — | — |
| 1588 | Pontosense Inc. | — | $4.4M |
| 1589 | NOVIS PRODUCTS, LLC | — | — |
| 1590 | NIRMIDAS BIOTECH, INC. | — | — |
| 1591 | HAYSTACK MEDICAL, INC. | — | — |
| 1592 | Beacon Point, LLC | — | $145M |
| 1593 | 4C Medical Technologies, Inc. | — | $136M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Assays, Sensing Platforms, And Methods For Diagnosis Of Coronavirus Infection And Re-infectiongranted
- New Saliva-based Lateral-flow Antibody Test Platform For Assessing Infections And Vaccination Efficacyapplication
- Methods And Systems For Diagnosis And Treatment Of Viral Infectionsgranted
- Test Strip For Short-wave Near Infrared Immunofluorescence Chromatographic Detection And Use Thereofapplication
- Metal Composites For Enhanced Imagingapplication
- Methods And Systems For Diagnosis And Treatmentapplication
- Enhanced Fluorescence Diagnostic Assayapplication
- Metal Composites For Enhanced Imagingapplication
- Metal Composites for Enhanced Imagingapplication
- Metal Composites for Enhanced Imagingapplication
- Saliva-based Lateral-flow Antibody Test Platform For Assessing Infections And Vaccination Efficacyapplication
- Assays, Sensing Platforms, And Methods For Diagnosis Of Coronavirus Infection And Re-infectionapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.